EU chemical industry: Good start to 2007, moderate slowdown expected for 2008
In its spring "Economic Outlook", Cefic expects output in the chemical industry (excluding pharmaceuticals) to grow by 2.7% in 2007, compared to 2.1% in 2006. The year 2008 may show a modest slowdown, possibly reaching growth of 2.3%.
The European chemical industry started the year 2007 on a positive note. During the 1st quarter, output of the chemical industry (excluding pharmaceuticals) rose by 3.6% compared to the same quarter of the previous year. The chemical business confidence index for the coming months remains at a high level. Most countries are likely to benefit from a relatively good macroeconomic environment for the EU, with strong domestic demand and favourable external EU trade development, and Germany acting as a locomotive within the European Union.
Industry generally seems to have coped better than expected with high oil prices. Despite the increase in oil prices over recent years, the dampening effects of oil prices on industrial activity have caused less damage than anticipated. The various chemical sectors are impacted to differing degrees by the global economic climate. Petrochemicals and polymers should show a recovery in 2007 after a very modest year 2006, mainly affected by maintenance problems.
Pharmaceuticals, less sensitive to cyclical factors, are expected to grow at their trend level (+5%) in 2007 after an excellent year 2006. Inorganic chemicals' growth should stabilise around 2%. Specialty chemicals are expected to be less dynamic in 2007, mainly affected by the slowdown in some major customer sectors such as construction. Consumer chemicals continue to benefit from the strong domestic demand and are expected to grow at above 4% in 2007.
Looking ahead, all chemical sub-sectors are expected to grow at a lower rate in 2008 due to the slowdown in global economic activity. In this context, Cefic expects for 2008 a production increase of 2.3 percent (excluding pharmaceuticals). Pharmaceutical production should continue to develop above average so that chemical production including pharmaceuticals should grow by 2.9 percent.
After a very good year 2006, the world economy is expected to lose some momentum in 2007 but growth remains fairly robust. One of the key factors is the mid-cycle slowdown of the US economy. Looking ahead, the world economy is likely to experience a slowdown in 2008. EU GDP is expected to grow by 2.7% in both 2007 and 2008.
Most read news
Organizations
Other news from the department business & finance
These products might interest you

Eclipse by Wyatt Technology
FFF-MALS system for separation and characterization of macromolecules and nanoparticles
The latest and most innovative FFF system designed for highest usability, robustness and data quality

HYPERION II by Bruker
FT-IR and IR laser imaging (QCL) microscope for research and development
Analyze macroscopic samples with microscopic resolution (5 µm) in seconds

Get the chemical industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Beckman Coulter to Acquire Biosite Incorporated
Hot Wheels: World Market for Styrene-Butadiene Rubber Analyzed
Diisobutylaluminium_hydride

ECOLAB Engineering GmbH - Siegsdorf, Germany
Dow and BASF win IChemE Award for jointly developed HPPO Technology

Bottled water can contain hundreds of thousands of previously uncounted tiny plastic bits - A new microscopic technique zeroes in on the poorly explored world of nanoplastics, which can pass into blood, cells and your brain
